Form 4: Cytokinetics Director Muna Bhanji Reports Stock Sale
SEC Filing
Director Muna Bhanji reported selling 1,454 shares of Cytokinetics Inc. common stock on May 15, 2025.
Summary
- On May 15, 2025, Muna Bhanji, a director of Cytokinetics Inc., sold 1,454 shares of common stock.
- The sale price was $29.73 per share.
- Following the transaction, Ms. Bhanji directly owns 23,510 shares of Cytokinetics Inc.
Sentiment
Score: 5
Explanation: This is a neutral report of a stock sale by a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 05/15/2025 | Date of transaction: Muna Bhanji sold 1,454 shares of Cytokinetics Inc. common stock. |
Keywords
Form 4, Cytokinetics, Stock Sale, Director, Bhanji, CYTK
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.